Mumbai; Maharashtra Government has announced plans to revive the Haffkine Institute for Public Health, which has faced financial difficulties since 2018-19.
The institute, known for producing healthcare products and exporting them to 45 countries, plays a role in global disease control efforts but has struggled in recent years.
As part of the plan, the institute will establish a Biosafety Level-3 (BSL-3) facility, a requirement for securing UNICEF’s approval for vaccine production. This will enable the institute to manufacture N-OPV vaccines and develop vaccines for future health emergencies.
The focus is on turning Haffkine into a centre for research and training.
The government aims to position the institute for long-term sustainability while maintaining its contributions to public health and vaccine development.
